Mechanical characterisation of an FDM 3D printing process

Elke Prasad; John Robertson; Gavin W. Halbert

Mechanical characterisation of an FDM 3D printing process

Elke Prasad, John Robertson, Gavin W. Halbert

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to conference › Poster › peer-review

18 Downloads (Pure)

Abstract

3D printing (3DP) of pharmaceutical formulations via commercially available FDM pinters has gained interested in recent years, enabling personalisation of medicines. It also facilitates advanced control of the microstructure of the tablet core, permitting fine tuning of product release characteristics with a single formulation. In addition, the technology also offers a platform for Dose escalation studies employing a single formulation and single manufacturing step. The objective of this study was to perform a mechanical characterisation of the extrusion of pharmaceutically relevant feedstock material during an FDM process.

Original language	English
Number of pages	1
Publication status	Published - 7 Sept 2021
Event	Virtual PharmSci : APS international conference - Duration: 7 Sept 2021 → 9 Sept 2021 https://www.apsgb.co.uk/event/virtual-aps-pharmsci-2021/#:~:text=Overview,%2C8th%20%26%209th%20September%202021.&text=Presentations%20on%20'Pharmaceutical%20Sciences%20and,Global%20COVID%2D19%20Pandemic'.

Conference

Conference	Virtual PharmSci
Period	7/09/21 → 9/09/21
Internet address	https://www.apsgb.co.uk/event/virtual-aps-pharmsci-2021/#:~:text=Overview,%2C8th%20%26%209th%20September%202021.&text=Presentations%20on%20'Pharmaceutical%20Sciences%20and,Global%20COVID%2D19%20Pandemic'.

Keywords

3D printing
mechanical testing
pharmaceutical formulation development
FDM (Fused Deposition Modeling)

Access to Document

Prasad-PharmSci-2021-Mechanical-characterisation-of-an-FDM-3D-printing-processFinal published version, 853 KB
Prasad-PharmSci-2021-Mechanical-characterisation-of-an-FDM-3D-printing-process-AUDIOOther version, 4.43 MB

Cite this

@conference{d0a458da9b814b7480417ce678ea178f,

title = "Mechanical characterisation of an FDM 3D printing process",

abstract = "3D printing (3DP) of pharmaceutical formulations via commercially available FDM pinters has gained interested in recent years, enabling personalisation of medicines. It also facilitates advanced control of the microstructure of the tablet core, permitting fine tuning of product release characteristics with a single formulation. In addition, the technology also offers a platform for Dose escalation studies employing a single formulation and single manufacturing step. The objective of this study was to perform a mechanical characterisation of the extrusion of pharmaceutically relevant feedstock material during an FDM process.",

keywords = "3D printing, mechanical testing, pharmaceutical formulation development, FDM (Fused Deposition Modeling)",

author = "Elke Prasad and John Robertson and Halbert, {Gavin W.}",

year = "2021",

month = sep,

day = "7",

language = "English",

note = "Virtual PharmSci : APS international conference ; Conference date: 07-09-2021 Through 09-09-2021",

url = "https://www.apsgb.co.uk/event/virtual-aps-pharmsci-2021/#:~:text=Overview,%2C8th%20%26%209th%20September%202021.&text=Presentations%20on%20'Pharmaceutical%20Sciences%20and,Global%20COVID%2D19%20Pandemic'.",

}

TY - CONF

T1 - Mechanical characterisation of an FDM 3D printing process

AU - Prasad, Elke

AU - Robertson, John

AU - Halbert, Gavin W.

PY - 2021/9/7

Y1 - 2021/9/7

N2 - 3D printing (3DP) of pharmaceutical formulations via commercially available FDM pinters has gained interested in recent years, enabling personalisation of medicines. It also facilitates advanced control of the microstructure of the tablet core, permitting fine tuning of product release characteristics with a single formulation. In addition, the technology also offers a platform for Dose escalation studies employing a single formulation and single manufacturing step. The objective of this study was to perform a mechanical characterisation of the extrusion of pharmaceutically relevant feedstock material during an FDM process.

AB - 3D printing (3DP) of pharmaceutical formulations via commercially available FDM pinters has gained interested in recent years, enabling personalisation of medicines. It also facilitates advanced control of the microstructure of the tablet core, permitting fine tuning of product release characteristics with a single formulation. In addition, the technology also offers a platform for Dose escalation studies employing a single formulation and single manufacturing step. The objective of this study was to perform a mechanical characterisation of the extrusion of pharmaceutically relevant feedstock material during an FDM process.

KW - 3D printing

KW - mechanical testing

KW - pharmaceutical formulation development

KW - FDM (Fused Deposition Modeling)

M3 - Poster

T2 - Virtual PharmSci

Y2 - 7 September 2021 through 9 September 2021

ER -

Mechanical characterisation of an FDM 3D printing process

Abstract

Conference

Keywords

Access to Document

Fingerprint

Cite this